[go: up one dir, main page]

MX2022016593A - Capsulas de gelatina blandas. - Google Patents

Capsulas de gelatina blandas.

Info

Publication number
MX2022016593A
MX2022016593A MX2022016593A MX2022016593A MX2022016593A MX 2022016593 A MX2022016593 A MX 2022016593A MX 2022016593 A MX2022016593 A MX 2022016593A MX 2022016593 A MX2022016593 A MX 2022016593A MX 2022016593 A MX2022016593 A MX 2022016593A
Authority
MX
Mexico
Prior art keywords
soft gelatin
gelatin capsules
gelatin capsule
supplement
soft
Prior art date
Application number
MX2022016593A
Other languages
English (en)
Inventor
Del Prado Jaime Moscoso
Katia Urso
Hernando Elena Pérez
Original Assignee
Itf Res Pharma Slu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Itf Res Pharma Slu filed Critical Itf Res Pharma Slu
Publication of MX2022016593A publication Critical patent/MX2022016593A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A61K31/6615—Compounds having two or more esterified phosphorus acid groups, e.g. inositol triphosphate, phytic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a cápsulas de gelatina blandas, al uso de la cápsula de gelatina blanda como complemento alimenticio, complemento nutricional y complemento dietético, a un procedimiento para preparar la cápsula de gelatina blanda, a la cápsula de gelatina blanda para su uso en medicina y a la cápsula de gelatina blanda para su uso en el tratamiento y/o la prevención de una enfermedad o patología.
MX2022016593A 2020-06-24 2021-06-24 Capsulas de gelatina blandas. MX2022016593A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20382554 2020-06-24
PCT/EP2021/067306 WO2021260093A1 (en) 2020-06-24 2021-06-24 Soft gelatin capsules

Publications (1)

Publication Number Publication Date
MX2022016593A true MX2022016593A (es) 2023-04-03

Family

ID=71575332

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022016593A MX2022016593A (es) 2020-06-24 2021-06-24 Capsulas de gelatina blandas.

Country Status (10)

Country Link
US (1) US20230263736A1 (es)
EP (1) EP4171519A1 (es)
JP (1) JP2023530747A (es)
KR (1) KR20230027221A (es)
CN (1) CN116018132A (es)
AU (1) AU2021298145A1 (es)
BR (1) BR112022026443A2 (es)
CA (1) CA3182980A1 (es)
MX (1) MX2022016593A (es)
WO (1) WO2021260093A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20240287094A1 (en) 2021-05-24 2024-08-29 Jiangsu Hengrui Pharmaceuticals Co., Ltd. Nitrogen-containing heterocyclic compound, preparation method therefor, and application thereof in medicines

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040043013A1 (en) * 2000-12-28 2004-03-04 Mccleary Edward Larry Metabolic uncoupling therapy
US20050002992A1 (en) * 2003-06-17 2005-01-06 Mccleary Edward Larry Foods, beverages, condiments, spices and salad dressings with specialized supplements
US20100056484A1 (en) * 2008-08-26 2010-03-04 Scott Farese Dietary supplemental composition effective for enhancing cognitive performance, elevating mood and reducing oxidative stress
GB201216385D0 (en) * 2012-09-13 2012-10-31 Chrysalis Pharma Ag A pharmaceutical composition
BR112015023215A2 (pt) * 2013-03-15 2017-07-18 Buck Inst Res Aging suplementos cognitivos aprimorados
US10517322B1 (en) * 2018-03-19 2019-12-31 Life Kitchen, LLC Dietary supplement formulations for promoting sleep
KR101936343B1 (ko) * 2018-06-22 2019-01-08 삼진제약주식회사 콜린알포세레이트를 포함하는 연질 캡슐

Also Published As

Publication number Publication date
AU2021298145A1 (en) 2023-02-09
EP4171519A1 (en) 2023-05-03
CA3182980A1 (en) 2021-12-30
KR20230027221A (ko) 2023-02-27
CN116018132A (zh) 2023-04-25
US20230263736A1 (en) 2023-08-24
JP2023530747A (ja) 2023-07-19
BR112022026443A2 (pt) 2023-01-31
WO2021260093A1 (en) 2021-12-30

Similar Documents

Publication Publication Date Title
Fda Dietary supplements
WO2010096564A4 (en) Dietary supplements containing polyunsaturated omega-3 fatty acids and probiotic bacteria with potential gastrointestinal and dermatological benefits
CN104758920A (zh) 一种基于药食同源的痛风保健品
MX2022016593A (es) Capsulas de gelatina blandas.
JP2014111647A (ja) 栄養剤、消化器剤
CN102972672A (zh) 一种用于补充营养的药物组合泡腾颗粒及其制备方法
JP7206223B2 (ja) パーキンソン病の予防および／または支持治療処置のための物質
CN101721403A (zh) 岩藻黄素在减肥方面的应用
JP2017114844A (ja) 認識能力向上食品
Shekhar et al. Nutraceuticals: A re-emerging health aid
PT1796702E (pt) Utilização de óleo de lavanda para profilaxia e tratamento de distúrbios de somatização e da doença de stress pós-traumático
CN102793167B (zh) 一种迷迭香抗氧化辅酶q10胶囊及其制备方法
JP6419620B2 (ja) 肩こり及び／又は目の充血改善剤
Lee A flood of health functional foods: what is to be recommended?
CN102813742A (zh) 一种具有改善营养性贫血的天然药食同源原料及制备方法
Van Schoor The value of supplements
CN106798342A (zh) 一种具有健脑功能的深海鱼低聚肽蛋白粉
Vagnini et al. The side effects bible: the dietary solution to unwanted side effects of common medications
Obiora et al. Use of Vegetable Mixture and Decoction of Some Vitamin C enriched Plants to Manage Hypertension in Jos, Nigeria: A Case Report
JP3179521U (ja) 健康食品
RU2467756C2 (ru) Способ получения из голотурий гомогенного стерилизованного раствора антиоксидантной направленности
CN108835629A (zh) 一种营养补充剂
Greer Study says hormone therapy for menopausal women should be restricted by dose, time
Bosch-Barrera Pemetrexed/silibinin
Simons The Components of Life: All about Vitamins, Minerals, Amino acids, Enzymes & Co.